Active substance
Etomidate
- US FDA 12
- Health Canada 2
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| AMIDATE | 2MG/ML | injectable · injection | HOSPIRA | Prescription | 7 Sep 1982 |
| ETOMIDATE | 2MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 4 Nov 1996 |
| ETOMIDATE | 2MG/ML | injectable · injection | ZYDUS PHARMS | Prescription | 18 Jul 2014 |
| ETOMIDATE | 2MG/ML | injectable · injection | HIKMA | Prescription | 25 Feb 2016 |
| ETOMIDATE | 2MG/ML | injectable · injection | MYLAN LABS LTD | Prescription | 7 Feb 2017 |
| ETOMIDATE | 2MG/ML | injectable · injection | EUGIA PHARMA | Prescription | 24 Feb 2017 |
| ETOMIDATE | 2MG/ML | injectable · injection | GLAND | Prescription | 18 Apr 2017 |
| ETOMIDATE | 2MG/ML | injectable · injection | CAPLIN | Prescription | 18 Dec 2020 |
| ETOMIDATE | 2MG/ML | injectable · injection | RISING | Discontinued | 2 Jan 2009 |
| ETOMIDATE | 2MG/ML | injectable · injection | LUITPOLD | Discontinued | 22 Dec 2009 |
| ETOMIDATE | 2MG/ML | injectable · injection | PH HEALTH | Discontinued | 20 Jun 2012 |
| ETOMIDATE | 2MG/ML | injectable · injection | AVET LIFESCIENCES | Discontinued | 13 Aug 2014 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ETOMIDATE INJECTION, USP | 02537508 | 2 MG / ML | SOLUTION · INTRAVENOUS | FRESENIUS KABI CANADA LTD |
| TOMVI | 02498650 | 2 MG / ML | SOLUTION · INTRAVENOUS | STERIMAX INC |
Safety signals and safety-related labeling changes
- US FDA 27 Apr 2017 AMIDATE — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.